简体中文 | 繁體中文 | English

Products & Services News

2022-10-28 18:16 Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials
2022-10-28 18:06 ULI Hines Student Competition Officially Launches in Asia Pacific
2022-10-28 14:04 Elliptic Labs and Xiaomi Launch the Redmi Note 12 Pro and Note 12 Pro+ Smartphones for the Chinese Market
2022-10-27 18:48 GTJAI Successfully Launched "China Funds Festival" Live Broadcast
2022-10-27 18:31 NTT Opens New Data Center in South Africa to Support Growing Digital Economy
2022-10-27 18:17 In Paris, FEELM Leads the Way in Disposable and Eco-Friendly Vaping Solutions
2022-10-27 16:42 Current Chemicals Showcases Next-Generation Display Technology at Phosphors & Quantum Dots Industry Forum 2022
2022-10-27 16:22 New Study from Egon Zehnder Finds Boards Need Four Key Ingredients to Become Stewards of Sustainability
2022-10-27 16:07 Mary Kay Announces Skin Health Grants and Delivers Eye-Opening Research on the Biology of Droopy Eyes at the 51st Annual European Society for Dermatological Research Meeting
2022-10-27 14:42 Exscientia Presents Novel Patient Stratification and Biomarker Data for GTAEXS-617 at the 34th EORTC-NCI-AACR Annual Symposium
2022-10-27 14:34 Prestige Biopharma Group to Exhibit at CPhI Frankfurt 2022
2022-10-27 13:37 Napier Introduces Advanced Financial Crime Risk Management Platform, Napier Continuum
2022-10-27 10:49 Tetrate Boosts Istio Adoption as Service Mesh Continues to Mature through a New CNCF Istio Course
2022-10-26 20:00 ICS® Diamond Tools and Equipment Is Rebranding to Oregon®
2022-10-26 19:24 Andersen Global Strengthens Slovakian Presence with Leading Law Firm
2022-10-26 19:20 European AI Startup Axelera AI Closes $27 Million Series A
2022-10-26 19:11 Bacardi Cuts Plastic in Packaging
2022-10-26 16:53 Ferring Presents Seven New Analyses at ACG 2022 for RBX2660, Its Investigational Microbiota-Based Live Biotherapeutic
2022-10-26 14:53 Merck Highlights New Data for Evobrutinib, First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment
2022-10-26 14:51 Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care